RecruitingNCT07229027
Global Overweight and oBesE (GLOBE) Patient Registry, Development and Implementation of Disease-specific: Severity, Quality of Life and Cost Instruments.
Sponsor
Medialis Ltd.
Enrollment
500 participants
Start Date
Nov 1, 2025
Study Type
OBSERVATIONAL
Conditions
Summary
We are conducting this study to develop a disease-specific instrument, a quality of life instrument and a comprehensive list of costs associated with overweight and obesity.
Eligibility
Min Age: 18 Years
Inclusion Criteria10
- Patient group
- Patient is aged ≥18 years at the time of survey completion.
- Patient has a BMI over 25 (self-reported)
- Patient is willing to participate in all study activities.
- Patient is able to read, write, and converse in English.
- Healthcare professional participant must meet the following criteria for inclusion in the study:
- HCP is aged ≥18 years at the time of survey completion.
- HCP is suitably qualified and involved in the healthcare management of patients with a BMI over 25
- HCP is willing to participate in all study activities.
- HCP is able to read, write, and converse in English.
Exclusion Criteria3
- A participant who meets any of the following criteria will be excluded from the study:
- Participants do not have the cognitive capacity to provide informed consent.
- Participants with severe co-morbidity that might affect study participation.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07229027
Related Trials
Anti-Inflammatory Effects of Pecan Nut Oil Supplementation in Adults With Overweight: A Randomized Controlled Parallel-Group Clinical Trial
NCT074975551 location
Time Restricted-EAting for Type 2 Diabetes and MEtabolic Health: the TEA TIME Trial
NCT072724601 location
Effect of Ketone Esters on Liver Fat Content and Metabolic Function
NCT070975061 location